Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome alterlation by ZIC5 knockdown in pancreatic cancer cell line, PANC-1.

ABSTRACT: To examine the transcriptome alterlation caused by ZIC5 knockdown in pancreatic cancer, we performed RNA-Seq analysis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE183860 | GEO | 2025/05/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptome alterlation by ZIC5 knockdown in pancreatic cancer cell line, PANC-1.

Project description:Transcriptome alterlation by ZIC5 knockdown in pancreatic cancer cell line, PANC-1.

| PRJNA762238 | ENA

Transcriptome alteration by ZIC5 knockdown in melanoma cell lines, A375 and SK-MEL-28.

Project description:To examine the transcriptome alteration caused by ZIC5 knockdown in melanoma, we performed gene expression microarray analysis.

2016-11-01 | GSE70223 | GEO

Transcriptome profile in SULF2 knockdown pancreatic tumor cells

Project description:Transcriptome profile in SULF2 knockdown pancreatic tumor cells

| PRJNA810844 | ENA

Transcriptome of Knockdown Pspc1 in the MS1 pancreatic islet endothelial cell line

Project description:Transcriptome of Knockdown Pspc1 in the MS1 pancreatic islet endothelial cell line

| PRJNA848769 | ENA

RNA sequence analysis of STYK1 knockdown in pancreatic cancer PANC-1 cells

Project description:Serine/threonine/tyrosine kinase 1 (STYK1), a proto-oncogenic transmembrane receptor alternatively termed NOK which consists of a kinase domain, intracellular domain, and transmembrane domain, was identified as an oncogene with high transformation potential in multiple cancer types. Recently, our group recognized that STYK1 depletion disrupts autophagosome biogenesis, establishing it as a critical modulator of autophagic flux. STYK1 was also reported as an oncogenic amplifier that hijacks KRAS effector networks, specifically the PI3K/AKT and MEK/ERK signaling axes, to drive tumor progression across malignancies. This molecular paradigm gains particular relevance in PDAC, where somatic KRAS mutations dominate (~95% prevalence) and functionally orchestrate pancreatic carcinogenesis from its earliest premalignant stages, notably during pancreatic intraepithelial neoplasia (PanIN) precursor lesions. This prompted a focused investigation into STYK1's functional implications within pancreatic cancer. By using multiple in vitro and in vivo assays, we figured out that higher STYK1 expression is related to poor pancreatic cancer survival and that STYK1 depletion suppresses pancreatic cancer cell development.To determine the molecular mechanism by which STYK1 promotes pancreatic cancer development, we performed RNA sequencing and found that STYK1 is involved in regulating the Wnt/β-Catenin signaling pathway. We also elucidate a novel STYK1-driven mechanism for Wnt/β-catenin activation in APC-independent pancreatic cancer and provide preclinical evidence for targeting STYK1-mediated signaling as a therapeutic strategy.

2025-07-09 | GSE298057 | GEO

RNA sequence analysis of STYK1 knockdown in pancreatic cancer PANC-1 cells

Project description:RNA sequence analysis of STYK1 knockdown in pancreatic cancer PANC-1 cells

| PRJNA1268203 | ENA

Expression data from TGF-beta treated Panc-1 pancreatic adenocarcinoma cell line

Project description:TGF-beta treatment of Panc-1 pancreatic adenocarcinoma cell line on Affymetrix HG_U133_plus_2 arrays; triplicate experiments. The goal of the experiment is to profile temporal gene expression changes during TGF-beta-induced epithelial-mesenchymal transition (EMT). During EMT cancer cells lose their epithelial specifc proteins and gain mesenchymal proteins to acquire migratory and invasive phenotype essential for metastasis. Human Panc-1 pancreatic adenocarcinoma cell line was treated with 5 ng/mL TGF-beta for 48 h to induce EMT. The experiment was repeated 3 times. Samples were assayed using Affymetrix HG_U133_plus_2 arrays with 54675 probe-sets, using standard techniques. Human Panc-1 pancreatic adenocarcinoma cell line was treated with 5 ng/mL TGF-beta for 48 h. The experiment was repeated 3 times. Samples were assayed using Affymetrix HG_U133_plus_2 arrays with 54675 probe-sets, using standard techniques.

2010-09-03 | E-GEOD-23952 | biostudies-arrayexpress

ac4C-seq in NAT10-knockdown PANC-1 cells

Project description:Pancreatic cancer is a lethal diease with high tendency of metastasis. Howerver, the mechanisms of pancreatic cancer are sitill unclear. To explore the roles of N4-acetylation (ac4C) RNA modification and its involved N-Acetyltransferase 10 (NAT10) in pancreatic ductal adenocarcinoma (PDAC), we performed profiling by high throughput sequencing. In this study, we investigate the effects of NAT10 knockdown on N4-acetylcytidine (ac4C) modification in mRNA within PANC-1 cells using ac4C-seq. By employing RNA interference to specifically knock down NAT10 expression in PANC-1 cells, we aim to elucidate its impact on ac4C RNA modifications, which have been implicated in various cellular processes and cancer progression. Total RNA was extracted and mRNA was captured and treated with sodium borohydride (NaBH4) for detection of ac4C sites.Following library preparation, sequencing was performed on an Illumina Novaseq 6000 platform. Bioinformatics analyses identified significant changes in ac4C modification patterns due to NAT10 depletion. This dataset provides a valuable resource for further exploration of ac4C modifications in mRNA and their role in PDAC.

2025-03-26 | GSE275963 | GEO

MCT4 knockdown in pancreatic cancer cells

Project description:Gene expression levels were determined with control or MCT4 knockdown pancreatic cancer cells.

2014-12-17 | GSE63231 | GEO

The effect of FOXO3 knockdown and PDHA1 knockdown on PDAC cell line Panc-1

Project description:Little is known about the role of FOXO3 and PDHA1 in PDAC. We performed microarrays to revealed the transcriptional change of a human pancreatic ductal adenocarcinoma (PDCA) cell line (Panc -1) to scr-siRNA, FOXO3-siRNA and PDHA1-siRNA in order to provide insight into the role of PDHA1 and FOXO3 in Panc-1 cells.

2016-09-01 | GSE66404 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data